Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia
Authors:
- 14 January 2014
- journal article
- basic science
- Published by Wolters Kluwer Health in AIDS
- Vol. 28 (2) , 181-186
Abstract
Objectives: To evaluate the relationship between incomplete antiretroviral therapy (ART) adherence and levels of residual HIV-1 viremia. Design: Medication adherence and residual viremia less than 50 copies/ml were quantified in participants of a cohort of homeless and marginally housed individuals with HIV/AIDS. Methods: Participants had at least 6 months of virologic suppression of less than 50 copies/ml and were in the adherence monitoring cohort with monthly unannounced pill counts. Residual viremia was measured by the single-copy assay. Results: The median average ART adherence over the prior 1 and 2 months were 94% [interquartile range (IQR) 79–100%] and 93% (IQR 82–98%), respectively. Average ART adherence over the past 2 months was significantly associated with levels of residual HIV viremia (Spearman r = –0.25, P = 0.04). One-third of participants with 100% ART adherence over the past 2 months had detectable residual viremia. On multivariate regression analysis, ART adherence over the past 2 months, but not duration of virologic suppression, CD4+ T-cell count or ART regimen, was significantly associated with levels of residual HIV viremia. Detectable residual viremia was associated with virologic failure (>50 copies/ml) on univariate Cox proportional hazard analysis (hazard ratio 2.08, P = 0.02). However, on multivariate analysis, only ART adherence was associated with risk of virologic failure. Conclusion: Incomplete ART adherence is associated with higher levels of residual HIV-1 viremia, but detectable residual viremia can be present despite 100% measured ART adherence.Keywords
This publication has 34 references indexed in Scilit:
- Increased Risk of Virologic Rebound in Patients on Antiviral Therapy with a Detectable HIV Load <48 Copies/mLPLOS ONE, 2012
- Adherence to Highly Active Antiretroviral Therapy in the Homeless Population in San Francisco: A Prospective StudyClinical Infectious Diseases, 2004
- Prevalence of antiretroviral drug resistance in the HIV-1-infected urban indigent population in San Francisco: a representative studyInternational Journal of STD & AIDS, 2004
- Screening and Behavioral Counseling Interventions in Primary Care To Reduce Alcohol Misuse: Recommendation StatementAnnals of Internal Medicine, 2004
- Intensification of Antiretroviral Therapy Accelerates the Decay of the HIV-1 Latent Reservoir and Decreases, But Does Not Eliminate, Ongoing Virus ReplicationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Productive Infection Maintains a Dynamic Steady State of Residual Viremia in Human Immunodeficiency Virus Type 1-Infected Persons Treated with Suppressive Antiretroviral Therapy for Five YearsJournal of Virology, 2003
- New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in PlasmaJournal of Clinical Microbiology, 2003
- HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination TherapyJAMA, 2001
- Non-adherence to highly active antiretroviral therapy predicts progression to AIDSAIDS, 2001
- Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS, 2000